Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive

Fertility and Sterility

Volumn 35, Issue 2, 1981, Pages 172-179

  Larsson Cohn, U ^a   Fahraeus, L ^a   Wallentin, L ^a   Zador, G ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ETHINYLESTRADIOL; LIPOPROTEIN; NORGESTREL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

CONTRACEPTION; DRUG ANALYSIS; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN;

EID: 0019420026     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)45318-5     Document Type: Article

References (25)

1. R.H. Furman Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease? Ann NY Acad Sci 149 1968 822
2. G. Heiss I. Tamir C.E. Davis H.A. Tyroler B.M. Rifkind G. Schonfeld D. Jacobs I.D. Frantz Lipoprotein-cholesterol distributions in selected North American populations: the Lipid Research Clinics Program prevalence study Circulation 61 1980 302
3. U. Larsson-Cohn R. Berlin O. Vikrot Effects of combined and low dose gestagen oral contraceptives on plasma lipids including individual phospholipids Acta Endocrinol (Kbh) 63 1970 717
4. U. Larsson-Cohn L. Wallentin G. Zador Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel Horm Metab Res 11 1979 437
5. B. Bagget H.A. Nash Effects of contraceptive steroids on serum lipoproteins and cardiovascular disease scrutinized at workshop in Bethesda Contraception 21 1980 115
6. T. Gordon W.P. Castelli M.C. Hjortland W.B. Kannel The prediction of coronary heart disease by high-density and other lipoproteins: an historical perspective B.M. Rifkind R.I. Levy Hyperlipidemia 1977 Grune and Stratton New York 71
7. V. Odlind E. Weiner A. Victor E.D.B. Johansson Effects of sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol Br J Obstet Gynaecol 87 1980 416
8. O. Vikrot Quantitative determination of plasma phospholipids in pregnant and non-pregnant women with special reference to lysolecithin Acta Med Scand 175 1964 443
9. Manual of Laboratory Operations, Vol 1: Lipid and Lipoprotein Analyses 1975 National Heart and Lung Institute, NIH Bethesda, Maryland (DHEW Publication No [NIH] 75-628)
10. W. Rosner A simplified method for the quantitative determination of testosterone-estradiol binding globulin activity in human plasma J Clin Endocrinol Metabol 34 1972 983
11. M. Briggs Hormonal contraceptives and plasma sex hormone binding globulin Contraception 12 1975 149
12. E. van Kammen J.H.H. Thijssen B. Rademaker F. Schwartz The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity Contraception 11 1975 53
13. M.N. El Makhzangy V. Wynn D.M. Lawrence Sex hormone binding globulin as an index of estrogenicity or androgenicity in women on oral contraceptive steroids Clin Endocrinol 10 1979 39
14. J.W. Goldzieher C.B. Chenault A. de la Pena T.S. Dozier D.C. Kraemer Comparative studies of the ethinyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles Fertil Steril 30 1978 522
15. L. Wallentin U. Larsson-Cohn Metabolic and hormonal effects of postmenopausal oestrogen replacement treatment. II. Plasma lipids Acta Endocrinol (Kbh) 86 1977 597
16. L. Wallentin U. Larsson-Cohn Postmenopausal oestrogen replacement and lipids Lancet 1 1977 1358
17. L. Wallentin E. Varenhorst Changes of plasma lipid metabolism in males during estrogen treatment for prostatic carcinoma J Clin Endocrinol Metabol 47 1978 596
18. L. Wallentin E. Varenhorst Plasma lipoproteins during treatment with cyproterone acetate in men with prostatic carcinoma J Clin Endocrinol Metabol 51 1980 1118
19. A. Gustafson A. Svanborg Gonadal steroid effects on plasma lipoproteins and individual phospholipids J Clin Endocrinol Metabol 35 1972 203
20. D.D. Bradley J. Wingard D.B. Petitti R.M. Krauss S. Ramcharan Serum high density lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins N Engl J Med 299 1978 17
21. S. Rössner U. Larsson-Cohn L.A. Carlsson J. Boberg Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the postheparin lipoprotein lipase activity Acta Med Scand 190 1971 301
22. G. Silferstolpe A. Gustafson G. Samsioe A. Svanborg Lipid metabolic studies in oophorectomized women. Effects of three different progestogens Acta Obstet Gynecol Scand 88 Suppl 1979 89
23. A.H. Kissebah P. Harrigan V. Wynn Mechanism of hypertriglyceridemia associated with contraceptive steroids Horm Metab Res 5 1973 184
24. D. Brunner J. Weisbort K. Loebl A. Schwartz J.E. Bearman S. Levin Serum cholesterol and high density lipoproteincholesterol in coronary patients and healthy persons Atherosclerosis 33 1979 9
25. H.J. Engel H. Hundeshagen P. Lichtlein Transmural myocardial infarction in young women taking oral contraceptives Br Heart J 39 1977 477